Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CBD Policies From CHPA, CRN Follow FDA; AHPA Acts Ahead Of Agency

Apr 04 2019

• By Malcolm Spicer

Cannibis

Related Content

FDA Opens CBD Regulatory Path Docket, Warns Firms On Claims Missteps

Apr 03 2019

FDA Clearing CBD As Dietary Ingredient? Legislation More Likely Than Rulemaking

Apr 02 2019

Wellness Industry News: MacKay Leaving CRN; Another Life-Line Recall, Ginkgo Bioworks' Second Startup, More

Mar 11 2019

CBD Drug Approval Not A Sign FDA Will Allow Its Use In Supplements

Jun 27 2018

Related Companies

GW Pharmaceuticals plc

Additional Topics

United States US States Advertising, Marketing & Sales Business Strategies Commercial Compliance Dietary Supplements Drug Approval Standards FDA Legislation OTC Drugs Policy Regulation Enforcement Consumer

More from Marketing & Advertising

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window